Results 171 to 180 of about 9,381 (304)
Completion of the Icatibant Outcome Survey and What We Learned
Clinical &Experimental Allergy, EarlyView.
Laurence Bouillet +8 more
wiley +1 more source
High Protistan Parasite Occurrence During Fall in a Warm, Low Sea Ice Year in the Eastern Bering Sea. [PDF]
Ladd TM +4 more
europepmc +1 more source
A time-series sediment trap experiment was conducted at 3,200 m in the Bering Sea Basin (53°30′N, 177°00′W; 3,788 m) during 1991 and 1992 to determine seasonal variation in the processes of biological production in the surface water of the Bering Sea ...
高橋, 孝三 +8 more
core
Summary Background and objectives Chronic pruritus (CP) significantly impairs quality of life (QoL), but existing patient‐reported QoL tools are either not specific for CP or are very extensive. Patients and methods The 5‐item pruritus life quality (5PLQ, range: 5–25, 7‐day recall) was developed to assess key itch‐related QoL domains (sensory symptoms,
Claudia Zeidler +14 more
wiley +1 more source
Current and future habitat suitability of northern fur seals and overlap with the commercial walleye pollock fishery in the eastern Bering Sea. [PDF]
McHuron EA +7 more
europepmc +1 more source
Bivalves in northern Bering Sea
Areal densities of two bivalve species (Macoma calcarea and Nuculana radiata) were measured in 1970-1974, 1993-1994, 1999, and 2001 on a sampling grid south of St.
core
ABSTRACT Aim Glucagon is a key regulator of glucose and energy metabolism, yet the dose–response effects of glucagon on markers of metabolism in humans are not fully characterised. We investigated the dose‐dependent effects of glucagon on glucose metabolism, β‐cell secretion and markers of hepatic metabolism in healthy adults.
Sophie Betty Brock +4 more
wiley +1 more source
Molecular Evaluation of the Mating Dynamics of Snow Crab (Chionoecetes opilio) in the Eastern Bering Sea. [PDF]
Slater LM +5 more
europepmc +1 more source
ABSTRACT Background Real‐world data on transfusion needs of patients with myelodysplastic syndromes (MDS), and the impacts of disease‐modifying therapies (DMTs) are sparse. In 2011, 5‐azacitidine became the first funded DMT for MDS and chronic myelomonocytic leukaemia (CMML) patients in Australia and national patient blood management (PBM) guidelines ...
Allison Mo +5 more
wiley +1 more source
ABSTRACT Introduction The 2024 ISTH clinical practice guideline (CPG) for treatment of congenital haemophilia, the NBDF‐McMaster Guideline on Care Models for Haemophilia Management, and ASH ISTH NBDF WFH guidelines on the diagnosis and management of VWD all utilised GRADE methodology.
Mark W. Skinner +59 more
wiley +1 more source

